PROVETOP

Biotinylated Human VEGF-C/Flt4-L Protein

Catalog No: VEGFC-HB001

Species
Human
Expression System
HEK293
Tag
His, Avi
Activity
Activity verified

Product overview

Recombinant Biotinylated Human VEGF-C/Flt4-L Protein is expressed in HEK293 cells with a His tag and Avi tag at the C-terminus. It contains amino acid residues Thr103-Arg227 (UniProt accession: Q6FH59).

Product Details

Molecular Aliases
VEGFC; VEGFc; Flt4-L; VRP; VEGF-C;Flt4L
Protein Length
Thr103-Arg227
Expression System
HEK293
Theoretical Molecular Weight
The protein has a predicted MW of 17.1 kDa. Due to glycosylation, the protein migrates to 23-30 kDa based on Bis-Tris PAGE result.
Purity
> 95% as determined by Bis-Tris PAGE
Endotoxin
Less than 1 EU per μg by the LAL method.
Buffer / Formulation
Lyophilized from 0.22μm filtered solution in 50mM MES, 150mM NaCl (pH 6.0). Normally 8% trehalose is added as protectant before lyophilization.
State
Lyophilized
Storage Conditions
-20 to -80°C for 12 months as supplied from date of receipt. -80°C for 3 months after reconstitution. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Reconstitution Advice
Dissolve the lyophilized protein in 50mM MES (pH 6.0). Please refer to the Certificate of Analysis for detailed instructions.

Data Display

Bis-Tris PAGE
VEGFC-HB001 Bis-Tris-PAGE-white result

Biotinylated Human VEGF-C on Bis-Tris PAGE under reduced (R) condition. The purity is greater than 95%.

ELISA
VEGFC-HB001 ELISA result

Immobilized Biotinylated Human VEGF-C, His Tag at 1μg/ml (100μl/well) on the streptavidin precoated plate (5μg/ml). Dose response curve for Human VEGF R3, hFc Tag with the EC50 of 8.2ng/ml determined by ELISA.

Background

the lymphangiogenic factors vascular endothelial growth factor C (VEGFC) and VEGFD are cleaved by thrombin and plasmin, serine proteases generated during hemostasis and wound healing. Genetic studies reveal that platelet enhancement of lymphatic growth after wounding is dependent on the release of VEGFC, but not VEGFD, a finding consistent with high expression of VEGFC in both platelets and avian thrombocytes.

References

  1. Lim L, Bui H, Farrelly O, Yang J, Li L, Enis D, Ma W, Chen M, Oliver G, Welsh JD, Kahn ML. Hemostasis stimulates lymphangiogenesis through release and activation of VEGFC. Blood. 2019 Nov 14;134(20):1764-1775. doi: 10.1182/blood.2019001736. PMID: 31562136; PMCID: PMC6856989.

Have questions about this product?

Our technical team can help with product selection, application questions and order support.

Contact Technical Support